Newsletter Subject

Don't drink bleach. Wear a mask for others.

From

arstechnica.com

Email Address

newsletters@arstechnica.com

Sent On

Wed, Apr 29, 2020 10:01 PM

Email Preheader Text

We're approaching the three-month mark for changing life in the US during its spread in China). And

[View this email in your browser]( [Open Ars Technica in your browser]( [Image] [Catalina, an island off the coast of California and the new MacOS release name.]( We're approaching the three-month mark for [the COVID-19 pandemic]( changing life in the US (and nearly five months since [the disease landed on the scientific radar]( during its spread in China). And while the devastation happening on the medical front lines (and increasingly on the industrial/economic front) is easy to come across, it remains hard to cut through the iterative, incessant updates to suss out the imperative information. Part of the problem is [some folks think they can benefit from disinformation]( and therefore feel incentivized to push hogwash (we see you, [Martin Shkreli](). Another issue is some critical information is deeply technical or involved, and it can be hard [to simply look at the raw data]( or information and take away the upshot or actionable info. Luckily, journalism institutions like Ars (or NPR, or the New York Times and Wall Street Journal, or The Verge and Wired, et al) exist for this exact kind of situation. For this week's Orbital Transmission, we're sharing a few of the most need-to-know updates that have come out after the initial wave of COVID-19 information hit the US en masse. There's still plenty of places around Ars to find some escapes (or at l[east some boardgames to better shelter-in-place](), but we're a scientific and technological news source at our core. There's no bigger story period right now than COVID-19, but that's especially true for those of us following science, health, medicine, and/or technology. —[@NathanMattise]( Orbital Transmission 04.29.2020 [(image) ]( [Nose-on: An at-home collection COVID-19 test]( The Seattle Coronavirus Assessment Network (SCAN) formed in March, but demand existed for its work long beforehand. As you've read and heard everywhere, testing for COVID-19 is key to understanding the best way forward when it comes to maintaining a healthy society and re-opening aspects of day-to-day life currently on pause. SCAN offered hundreds of free, at-home tests so long as you signed up—receive the kit at 11a, return it by 4p, get the results ASAP that week. Ars' Seattle-ite Sam Machkovech recently went through the process and shared his experience (and all the technical details). The TL;DR? SCAN's effort to quickly gather data from a wide range of Seattle-area residents—aided by an efficient, same-day pickup process—comes at the cost of precision, but that's less of a knock on SCAN's remarkable free-test efforts and more of a reminder of the scale of the COVID-19 crisis. [(image) ]( [Go ahead and stop that person about to bring up the flu's severity]( The (generously termed) ill-informed backers of "but the flu is just as bad if not worse!" argument hopefully saw the news this week. Yes, a pair of studies recently came out looking at the spread of COVID-19 in California, and that tandem gained a lot of publicity for suggesting death rates are actually more akin to the flu. But—and here's the important bit—neither study has been published in a scientific journal, nor have they gone through standard peer-review for scientific vetting. Instead, they have been posted online in draft form. That's a commonplace occurrence amid a rapidly evolving pandemic that inclines researchers to have fast access to data (however uncertain), but it also means folks looking to cherrypick "evidence" can act in a bad faith manner and shout about what they like without highlighting the limitations. Luckily, frustrated statisticians and epidemiologists haven't been afraid to get vocal about all the BS stemming from this situation. [(image) ]( [Don't believe everything you hear about "medicine" like bleach and chloroquine]( We don't need to rehash the details of how these two proposed COVID-19 "cures" or "treatments" came into the popular consciousness, but let's just say a peer-reviewed scientific paper was not the catalyst. The recent rise of people crying for hydroxychloroquine ([or, worse, bleach]() should serve as a reminder to not believe everything you hear coming from politicians, particularly those with a history of dismissing science. The FDA had to recently issue a safety announcement regarding hydroxychloroquine (the drugs' use "should be limited to clinical trial settings or for treating certain hospitalized patients") and literally people [will poison themselves with disinfectant nonsense](. Do not. [(image) ]( [Since we'll be needing 'em, here's what to know about masks]( No matter what stage of COVID-19 life your area is within, the reality going forward has a commonality—masks. Open now, open later, stay sheltered-in-place, government officials and health experts seem to at least agree upon the potential benefit of wearing masks when in public areas around others. "Potential" is the key word there, as masks are definitively not a cure-all for the coronavirus situation and are genuinely less effective than avoiding those kinds of close contact situations to begin with. But if large swaths of society insist on pushing forward at rates scientists may disagree with, understanding the limitations of masks (and the need for more testing around them in the broader scientific community) may help the rest of us make more informed, cautious, and safer decisions about where to go and how to do it. [Facebook]( [Twitter]( [YouTube]( [Instagram]( Copyright © 2020 Condé Nast, All rights reserved. Our mailing address is: Condé Nast One World Trade Center New York, NY 10007 Want to change how you receive these emails? You can [update your preferences](newsletter=ars) or [unsubscribe from this list](newsletter=ars).

Marketing emails from arstechnica.com

View More
Sent On

06/11/2024

Sent On

02/10/2024

Sent On

25/09/2024

Sent On

18/09/2024

Sent On

11/09/2024

Sent On

04/09/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.